| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |